메뉴 건너뛰기




Volumn 22, Issue , 2015, Pages 1-3

Estimating HCV disease burden - Volume 3 (editorial)

Author keywords

diagnosis; disease burden; epidemiology; hepatitis C; hepatitis C virus; prevalence; strategy; sustained viral response; therapies; total infections; treatment

Indexed keywords

ANTIVIRAL THERAPY; DISEASE SEVERITY; EDITORIAL; ESTONIA; FIBROSIS; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 2; HEPATITIS C VIRUS GENOTYPE 3; HEPATITIS C VIRUS GENOTYPE 4; HUMAN; HUNGARY; ICELAND; INDONESIA; INTERFERON FREE DIRECT ACTING ANTIVIRAL THERAPY; IRAN; JAPAN; LATVIA; LEBANON; LITHUANIA; LIVER DISEASE; PAKISTAN; PREVALENCE; PRIORITY JOURNAL; ROMANIA; SAUDI ARABIA; SLOVENIA; SOUTH KOREA; SUSTAINED VIROLOGICAL RESPONSE; TREATMENT RESPONSE; UNITED ARAB EMIRATES; HEALTH; HEPACIVIRUS; HEPATITIS C, CHRONIC; ISOLATION AND PURIFICATION;

EID: 84945395368     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12473     Document Type: Editorial
Times cited : (8)

References (6)
  • 1
    • 84904720839 scopus 로고    scopus 로고
    • Historical epidemiology of hepatitis C virus (HCV) in selected countries
    • Bruggmann P, Berg T, Ovrehus AL, et al,. Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat 2014; 21 (Suppl. 1): 5-33.
    • (2014) J Viral Hepat , vol.21 , pp. 5-33
    • Bruggmann, P.1    Berg, T.2    Ovrehus, A.L.3
  • 2
    • 84902136664 scopus 로고    scopus 로고
    • The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
    • Razavi H, Waked I, Sarrazin C, et al,. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat 2014; 21 (Suppl. 1): 34-59.
    • (2014) J Viral Hepat , vol.21 , pp. 34-59
    • Razavi, H.1    Waked, I.2    Sarrazin, C.3
  • 3
    • 84902129061 scopus 로고    scopus 로고
    • Strategies to manage hepatitis C virus (HCV) disease burden
    • Wedemeyer H, Duberg AS, Buti M, et al,. Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat 2014; 21 (Suppl. 1): 60-89.
    • (2014) J Viral Hepat , vol.21 , pp. 60-89
    • Wedemeyer, H.1    Duberg, A.S.2    Buti, M.3
  • 4
    • 84920274258 scopus 로고    scopus 로고
    • Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2
    • Saraswat V, Norris S, de Knegt RJ, et al,. Historical epidemiology of hepatitis C virus (HCV) in select countries-volume 2. J Viral Hepat 2015; 22 (Suppl 1): 6-25.
    • (2015) J Viral Hepat , vol.22 , pp. 6-25
    • Saraswat, V.1    Norris, S.2    De Knegt, R.J.3
  • 5
    • 84920270905 scopus 로고    scopus 로고
    • The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - Volume 2
    • Hatzakis A, Chulanov V, Gadano AC, et al,. The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm-volume 2. J Viral Hepat 2015; 22 (Suppl 1): 26-45.
    • (2015) J Viral Hepat , vol.22 , pp. 26-45
    • Hatzakis, A.1    Chulanov, V.2    Gadano, A.C.3
  • 6
    • 84920279600 scopus 로고    scopus 로고
    • Strategies to manage hepatitis C virus (HCV) infection disease burden - Volume 2
    • Gane E, Kershenobich D, Seguin-Devaux C, et al,. Strategies to manage hepatitis C virus (HCV) infection disease burden-volume 2. J Viral Hepat 2015; 22 (Suppl 1): 46-73.
    • (2015) J Viral Hepat , vol.22 , pp. 46-73
    • Gane, E.1    Kershenobich, D.2    Seguin-Devaux, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.